Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Praticien-chercheur
14 articles scientifiques publiés — formation continue solide
Délais de RDV courts dans la région
151.5 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
CHMS - SITE CHAMBERY MCO
PL LUCIEN BISET BP 31125, 73011 CHAMBERY CEDEX
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
The Journal of clinical endocrinology and metabolism · 2000
Abstract A major determinant of the risk for osteoporosis is peak bone mineral density (BMD), which is largely determined by genetic factors. We recently reported linkage of peak BMD in a large sample of healthy sister pairs to chromosome 11q12–13. To identify additional loci underlying normal variations in peak BMD, we conducted an autosomal genome screen in 429 Caucasian sister pairs. Multipoint LOD scores were computed for BMD at four skeletal sites. Chromosomal regions with LOD scores above 1.85 were further pursued in an expanded sample of 595 sister pairs (464 Caucasians and 131 African-Americans). The highest LOD score attained in the expanded sample was 3.86 at chromosome 1q21–23 with lumbar spine BMD. Chromosome 5q33–35 gave a LOD score of 2.23 with femoral neck BMD. At chromosome 6p11–12, the 464 Caucasian pairs achieved a LOD score of 2.13 with lumbar spine BMD. Markers within the 11q12–13 region continued to support linkage to femoral neck BMD, although the peak LOD score was decreased to 2.16 in the sample of 595 sibling pairs. Our study is the largest genome screen to date for genes underlying variations in peak BMD and represents an important step toward identifying genes contributing to osteoporosis in the general population.
The American journal of medicine · 2017
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 1998
Abstract Osteoporosis is a leading public health problem that is responsible for substantial morbidity and mortality. A major determinant of the risk for osteoporosis in later life is bone mineral density (BMD) attained during early adulthood. BMD is a complex trait that presumably is influenced by multiple genes. Recent linkage of three Mendelian BMD-related phenotypes, autosomal dominant high bone mass, autosomal recessive osteoporosis-pseudoglioma, and autosomal recessive osteopetrosis to chromosome 11q12–13 led us to evaluate this region to determine if the underlying gene(s) could also contribute to variation in BMD in the normal population. We performed a linkage study in a sample of 835 premenopausal Caucasian and African–American sisters to identify genes underlying BMD variation. A maximum multipoint LOD score of 3.50 with femoral neck BMD was obtained near the marker D11S987, in the same chromosomal region as the three Mendelian traits mentioned above. Our results suggest that the gene(s) underlying these Mendelian phenotypes also play a role in determining peak BMD in the normal population and are the first using linkage methods to establish a chromosomal location for a gene important in determining peak BMD. These findings support the hypothesis that a gene responsible for one or more of the rare Mendelian BMD traits linked to chromosome 11q12–13 has an important role in osteoporosis in the general population.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2018 · Published Erratum
Gillespie CW, Morin PE
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2017 · Journal Article
Gillespie CW, Morin PE
The American journal of medicine · 2017 · Journal Article
Gillespie CW, Morin PE
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2004 · Journal Article
Moffett SP, Zmuda JM, Cauley JA, Stone KL, et al.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 1998 · Journal Article
Koller DL, Rodriguez LA, Christian JC, Slemenda CW, et al.
Revue neurologique · 1989 · English Abstract
Viader F, Poncelet AM, Chapon F, Thenint JP, et al.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques · 1987 · Case Reports
Thenint JP, Penniello MJ, Chapon F, Viader F, et al.
Revue du rhumatisme et des maladies osteo-articulaires · 1984 · Journal Article
Brousse A, Le Goff P, Morin PP
Bulletins et memoires de la Societe medicale des hopitaux de Paris · 1957 · Journal Article
NICK J, CONTAMIN F, HARL JM, MORIN P
The Journal of clinical endocrinology and metabolism · 2005 · Journal Article
Moffett SP, Zmuda JM, Oakley JI, Beck TJ, et al.
The American journal of medicine · 2003 · Journal Article
Ziv E, Kahn A, Cauley J, Morin P, et al.
The Journal of clinical endocrinology and metabolism · 2000 · Clinical Trial
Koller DL, Econs MJ, Morin PA, Christian JC, et al.
Cells, tissues, organs · 2005 · Clinical Trial
Kopp S, Alstergren P, Ernestam S, Nordahl S, et al.
Cells, tissues, organs · 2005 · Clinical Trial
Kopp S, Alstergren P, Ernestam S, Nordahl S, et al.
Gynecologie et obstetrique · 1970 · Journal Article
Morin P, Kahn F, Waterhouse C